In recent years, the treatment of drug-resistant epilepsy (DRE) has made greater use of surgery and expanded options for neurostimulation or neuromodulation. Up to this point, responsive neurostimulation (RNS) has been very promising but has mainly used only the cortex as a target. In this individual patient data meta-analysis (IPDMA), the authors sought to establish if a novel RNS target, the thalamus, can be used to treat DRE.
The literature regarding the management of DRE by targeting the thalamus with RNS was reviewed per IPDMA guidelines. Five databases were searched with keywords [((Responsive neurostimulation) OR (RNS)) AND ((thalamus) OR (thalamic) OR (Deep-seated) OR (Diencephalon) OR (limbic))] in March 2022.
The median (interquartile range) age at implantation was 17 (13.5–27.5) years (n = 42) with an epilepsy duration of 12.1 (5.8–15.3) years. In total, 52.4% of patients had previously undergone epilepsy surgery, 28.6% had prior vagus nerve stimulation, and 2.4% had prior RNS. The median preimplant seizure frequency was 12 per week. The median seizure reduction at last follow-up was 73%. No study in this IPDMA reported complications, although 7 cases (16.3%) did require reoperation. Behavioral improvements and reduced antiepileptic drug dose or quantity were reported for 80% and 28.6% of patients, respectively.
This review indicates that thalamic RNS may be safe and effective for treating DRE. Long-term and controlled studies on thalamic RNS for DRE would further elucidate this technique’s potential benefits and complications and help guide clinical judgment in the management of DRE.
INCLUDE WHEN CITINGPublished online June 16, 2023; DOI: 10.3171/2023.5.PEDS22559.
DisclosuresThe authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
DeGiorgioCM,KrahlSE.Neurostimulation for drug-resistant epilepsy.Continuum (Minneap Minn).2013;19(3 Epilepsy):743–755.
KlingerN,MittalS.Deep brain stimulation for seizure control in drug-resistant epilepsy.Neurosurg Focus.2018;45(2):E4.
NairDR,宽松的KD,WeberPB,et al.Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy.Neurology.2020;95(9):e1244–e1256.
SalanovaV,WittT,WorthR,et al.Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.Neurology.2015;84(10):1017–1025.
PageMJ,MoherD,BossuytPM,et al.PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.BMJ.2021;372(160):n160.
BeaudreaultCP,MuhCR,NaftchiA,et al.Responsive neurostimulation targeting the anterior, centromedian and pulvinar thalamic nuclei and the detection of electrographic seizures in pediatric and young adult patients.Front Hum Neurosci.2022;16:876204.
BurdetteD,MirroEA,LawrenceM,PatraSE.Brain-responsive corticothalamic stimulation in the pulvinar nucleus for the treatment of regional neocortical epilepsy: a case series.Epilepsia Open.2021;6(3):611–617.
BurdetteDE,HaykalMA,JarosiewiczB,et al.Brain-responsive corticothalamic stimulation in the centromedian nucleus for the treatment of regional neocortical epilepsy.Epilepsy Behav.2020;112:107354.
ElderC,FriedmanD,DevinskyO,DoyleW,DuganP.Responsive neurostimulation targeting the anterior nucleus of the thalamus in 3 patients with treatment-resistant multifocal epilepsy.Epilepsia Open.2019;4(1):187–192.
HerlopianA,CashSS,EskandarEM,JenningsT,ColeAJ.Responsive neurostimulation targeting anterior thalamic nucleus in generalized epilepsy.Ann Clin Transl Neurol.2019;6(10):2104–2109.
KokkinosV,UrbanA,SistersonND,LiN,CorsonD,RichardsonRM.Responsive neurostimulation of the thalamus improves seizure control in idiopathic generalized epilepsy: a case report.开云体育app官方网站下载入口.2020;87(5):E578–E583.
KokoszkaMA,PanovF,La Vega-TalbottM,McGoldrickPE,WolfSM,GhatanS.Treatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases.J Neurosurg Pediatr.2018;21(4):421–427.
KwonCS,SchupperAJ,FieldsMC,et al.Centromedian thalamic responsive neurostimulation for Lennox-Gastaut epilepsy and autism.Ann Clin Transl Neurol.2020;7(10):2035–2040.
PanovF,GanahaS,HaskellJ,et al.Safety of responsive neurostimulation in pediatric patients with medically refractory epilepsy.J Neurosurg Pediatr.2020;26(5):525–532.
SistersonND,KokkinosV,UrbanA,LiN,RichardsonRM.Responsive neurostimulation of the thalamus improves seizure control in idiopathic generalised epilepsy: initial case series.J Neurol Neurosurg Psychiatry.2022;93(5):491–498.
WelchWP,HectJL,AbelTJ.Case report: responsive neurostimulation of the centromedian thalamic nucleus for the detection and treatment of seizures in pediatric primary generalized epilepsy.Front Neurol.2021;12:656585.
RyanR,HillS.How to GRADE the quality of the evidence.Version 3.0. Cochrane Consumers and Communication Group.Published December 1, 2016. Accessed May 15, 2023.http://cccrg.cochrane.org/author-resources
LeeB,ZubairMN,MarquezYD,et al.A single-center experience with the NeuroPace RNS system: a review of techniques and potential problems.World Neurosurg.2015;84(3):719–726.
NagahamaY,ZervosTM,MurataKK,et al.Real-world preliminary experience with responsive neurostimulation in pediatric epilepsy: a multicenter retrospective observational study.开云体育app官方网站下载入口.2021;89(6):997–1004.
FattorussoA,MatricardiS,MencaroniE,et al.pharmacoresistant癫痫:概述on existant and new emerging therapies.Front Neurol.2021;12:674483.
GellerEB,SkarpaasTL,GrossRE,et al.Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.Epilepsia.2017;58(6):994–1004.
MaBB,FieldsMC,KnowltonRC,et al.Responsive neurostimulation for regional neocortical epilepsy.Epilepsia.2020;61(1):96–106.
MorrellM.Nine-year prospective safety and effectiveness outcomes from the long-term treatment trial of the RNS® system.Brain Stimul.2019;12(2):469.
MorrellMJ.Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.Neurology.2011;77(13):1295–1304.
RinconN,BarrD,Velez-RuizN.Neuromodulation in drug resistant epilepsy.Aging Dis.2021;12(4):1070–1080.
JennyB,SmollN,El HassaniY,et al.Pediatric epilepsy surgery: could age be a predictor of outcomes?J Neurosurg Pediatr.2016;18(2):235–241.
KahlowH,OlivecronaM.Complications of vagal nerve stimulation for drug-resistant epilepsy: a single center longitudinal study of 143 patients.Seizure.2013;22(10):827–833.
NuneG,DeGiorgioC,HeckC.Neuromodulation in the treatment of epilepsy.Curr Treat Options Neurol.2015;17(10):375.
AldenkampAP,Van de VeerdonkSHA,MajoieHJM,et al.Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with Lennox-Gastaut syndrome in an open clinical and nonrandomized study.Epilepsy Behav.2001;2(4):343–350.
KokoszkaMA,McGoldrickPE,La Vega-TalbottM,et al.Epilepsy surgery in patients with autism.J Neurosurg Pediatr.2017;19(2):196–207.
ParkYD.The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism.Epilepsy Behav.2003;4(3):286–290.
BergAT,LoddenkemperT,BacaCB.Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care.Epilepsia.2014;55(1):123–132.
JobstBC,CascinoGD.Resective epilepsy surgery for drug-resistant focal epilepsy: a review.《美国医学会杂志》.2015;313(3):285–293.
Téllez-ZentenoJF,DharR,WiebeS.Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis.Brain.2005;128(Pt 5):1188–1198.
YardiR,Morita-ShermanME,FitzgeraldZ,et al.Long-term outcomes of reoperations in epilepsy surgery.Epilepsia.2020;61(3):465–478.
LuVM,BrownEC,RaghebJ,WangS.Repeat surgery for pediatric epilepsy: a systematic review and meta-analysis of resection and disconnection approaches.J Neurosurg Pediatr.2022;30(6):616–623.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 626 | 626 | 150 |
Full Text Views | 74 | 74 | 24 |
PDF Downloads | 111 | 111 | 44 |
EPUB Downloads | 0 | 0 | 0 |